Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). 

Pharmaceutical

Karyopharm Therapeutics

Karyopharm Therapeutics' headquarters in Newton, MA, United States

Richard Paulson

Reshma Rangwala

Andrew Lancaster

Stephanie Quigley

Stuart Poulton

Michael Method

Lisa A. Dipaolo

Lori Macomber

Stephen Li

Lisa DiPaolo

Mike Mano

Sohanya Cheng

Brian Austad

Barry E. Greene

Garen Bohlin

Chen Schor

Christy J. Oliger

Mansoor Raza Mirza

Deepa R. Pakianathan

Zhen Su

The Leadership Team at Karyopharm Therapeutics is responsible for guiding the company's strategic direction and overall operations. Comprising executives from various disciplines, including research, commercial strategy, regulatory affairs, and investor relations, this team collaborates to drive innovation in drug development, ensure compliance with industry standards, and optimize business practices to successfully bring novel therapeutic solutions to market. Their collective expertise enables Karyopharm to effectively navigate challenges and capitalize on opportunities in the pharmaceutical landscape.

Leadership Team

The Research and Development team at Karyopharm Therapeutics focuses on advancing innovative drug candidates through comprehensive preclinical and clinical research. This multidisciplinary team collaborates on drug discovery, clinical strategy, regulatory affairs, and pharmacovigilance to ensure the safety and efficacy of novel therapies targeting cancer and other diseases. Their expertise spans various scientific and medical fields, driving the translation of groundbreaking research into potential treatment options.

Research and Development

The Marketing and Communications team at Karyopharm Therapeutics is responsible for shaping and promoting the company's brand, engaging stakeholders, and communicating the value of its innovative therapies. This team collaborates across functions to develop strategic marketing initiatives, manage external partnerships, and facilitate comprehensive market access strategies that enhance the understanding and accessibility of Karyopharm's pioneering treatments for cancer and other serious conditions.

Marketing and Communications

The Clinical Operations team at Karyopharm Therapeutics is responsible for the planning, execution, and oversight of clinical trials to ensure the safe and efficient development of innovative therapies. This team collaborates closely with various stakeholders, manages clinical supply logistics, and ensures compliance with regulatory standards, all while driving the advancement of clinical programs that focus on the company's novel SINE compounds for cancer treatment.

Clinical Operations

The Finance and Accounting team at Karyopharm Therapeutics plays a critical role in managing the company’s financial health and compliance. This team is responsible for overseeing budgeting, financial planning, accounting operations, and reporting, while ensuring adherence to legal and regulatory standards. By analyzing financial data and streamlining financial processes, they support strategic decision-making that drives the company’s mission of developing innovative treatments for cancer and other diseases.

Finance and Accounting

The Legal and Compliance team at Karyopharm Therapeutics ensures the company adheres to all regulatory requirements and industry standards while advancing its innovative drug development. This team is responsible for managing legal matters, overseeing advertising and promotional activities, ensuring compliance with healthcare regulations, and maintaining effective contract management and training processes. Their work protects the company’s interests while facilitating ethical practices in the commercialization of novel therapeutics.

Karyopharm Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Marketing and Communications

Clinical Operations

Finance and Accounting

Legal and Compliance

Offices

Karyopharm Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Research and Development

Marketing and Communications

Clinical Operations

Finance and Accounting

Legal and Compliance

Offices

Related companies